RESTRICTIONS RELATING TO U.S. PERSONS

If you are a U.S. Person or reside in the United States, you may not view the materials linked herein, and you must click to exit this page.

The information contained on the following pages of our web site is restricted and may not be viewed by U.S. persons or any person located in the United States. This information relates to an offering of securities by Nutri Pharma ASA (the “Company”) which is not a public offering in the United States and therefore applicable U.S. law strictly limits access to this information.

The material in the following pages is strictly confidential and is being furnished by the Company as part of an offering exempt from registration under the U.S. Securities Act. The securities will not be offered or sold to U.S. Persons as defined in Regulation S under the U.S. Securities Act, unless the Company determines in its sole discretion that it may do so under an applicable exemption from the registration requirements of the U.S. Securities Act and the relevant state securities laws.

The delivery of the Offering Circular and the attached subscription material in whole or in part, and any disclosure of its contents or use of any information herein for any purpose other than considering an investment in the Shares in the Company is prohibited. The following materials may not, in whole or in part, be reproduced, copied or forwarded to any U.S. person or any person located in the United States. Because the Offering Circular and related subscription materials may only be viewed by non-U.S. persons you must accurately complete each of the confirmations set forth below to enter this service. If you cannot make both confirmations set forth below, you are required by applicable law to EXIT this page.

I confirm that I am not accessing this web site from the United States

I confirm that I am not a U.S. Person.

 
 

Oslo Børs

 

Kontaktinfo

Adresse:

Pareto Securities AS
Dronning Mauds gt. 3
P.O. Box 1411 Vika
N-0115 Oslo
Norway

Telefon:

+47 22 87 87 00

Telefaks:

+47 22 87 87 10